Delivery Order SPE2DB20D2104-SPE2DB22FT07Y
- Not listed
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the Defense Logistics Agency (DLA), a defense agency. The $48,309.89 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $3,860.60 firm fixed price delivery order has a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities,...
- This federal contract award is for the delivery of RABAVERT rabies vaccine and diluents, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,960.11 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 17, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award is for the supply of RABAVERT Rabies Vaccine with diluents, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,441.89 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through July 2, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of RABAVERT rabies vaccine with diluents. The $1,737.27 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. No set-aside designations were used. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the U.S. Defense Logistics Agency (DLA). The $3,860.60 firm fixed price contract was awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds several large indefinite delivery contracts (IDCs) with the DLA and other federal agencies. The contract has no set-aside designation and is a delivery order awarded under Amerisourcebergen's...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,095.80 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,951.97 firm fixed-price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 29, 2023. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,997.00, is for the delivery of RABAVERT Rabies Vaccine with diluents. This appears to be a Firm Fixed Price Delivery Order contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB22FT07YDelivery Order
This federal contract award is for the delivery of RABAVERT RABIES VACCINE with diluents, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $2,898.60 and is a firm fixed-price delivery order. It does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as AmerisourceBergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award for the rabies vaccine is likely a specific delivery order under the larger IDC. Additionally, AmerisourceBergen holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/22/22 |